Requiring that certain advertisements for medical cannabis, medical cannabis products, or medical cannabis-related services be supported by substantial clinical evidence or data and include information about side effects or risks associated with the use of cannabis; prohibiting advertisements from being false or misleading or from containing certain designs, pictures, illustrations or representations; requiring any website owned, managed, or operated by certain providers to employ a neutral age-screening mechanism; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2019
( 13-3313.1 )
Last Updated: 2/3/2020 2:35 PM